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Abstract 
Microtubules in the hepatocytes have been implicated to serve as lines of cytoplasmic transport of secretory materials, but are highly 
labile structures ensitive to pathological conditions in the cytosol. We examined the role of ischemia/reperfusion-induced cytoskeletal 
alterations in postischemic liver dysfunction. Rabbit livers were subjected to 60-min warm ischemia followed by 1 h or 24 h of 
reperfusion. Liver function was assessed by directly measuring hepatic learance of indocyanine green (ICG), an organic anion whose 
cytoplasmic transport is assumed to depend on intact microtubules, using near-infrared spectroscopy. Structural alterations of micro- 
tubules were observed immunohistochemically using tissue sections tained with monoclonal nti-13-tubulin a tibody. ICG removal from 
hepatocytes into bile canaliculi deteriorated 1 h but reversed 24 h after reperfusion. Immunohistochemistry howed fragmentation f
microtubules at the end of liver ischemia. This cytoskeletal lteration was evident 1 h but was not observed 24 h after reperfusion. 
Treatment with prostaglandin E 1 exerted its beneficial effect by preserving ICG clearance and microtubular network. These results 
demonstrate hat liver ischemia and subsequent reperfusion both affect the organization of microtubular network and suggest hat 
structural disruption of microtubules may be a cause of postischemic liver dysfunction. 
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I. Introduction 
Liver injury and the resultant dysfunction from is- 
chemia/reperfusion remain major clinical problems in the 
surgical field. A great deal of investigation has ascribed 
the cause to disruption of liver cell membrane structures. 
Insufficient energy production in mitochondria [1], Ca 2+ 
accumulation i the cytosol [2,3], and oxygen free radicals 
[4,5], were all proposed as possible mechanisms for the 
pathogenesis of phospholipid degradation or lipid per- 
oxidation observed in the postischemic ell membrane. 
Abbreviations: ICG, indocyanine green; GTP, guanosine triphosphate; 
ATP, adenosine triphosphate; PGE I, prostaglandin Ej; FITC, fluorescein 
isothiocyanate; MAPs, microtubule associated proteins; PGE2, prosta- 
glandin E 2. 
* Corresponding author. Fax: + 81 (75) 7513106. 
Present address: Department ofAnatomy and Cell Biology, School of 
Medicine, Gunma University, Maebashi 371, Japan. 
However, the precise mechanism underlying postischemic 
liver dysfunction is not well understood. 
The cytoskeleton, cytoplasmic networks of protein fila- 
ments consisting of three principal types of structures - -  
microfilaments, microtubules, and intermediate filaments 
- -  not only works to maintain cell shape but provides the 
machinery for cell functions. In the liver, microtubules are 
involved in cytoplasmic transport of various secretory 
materials including albumin [6], biliary lipids such as 
phospholipid and cholesterol [7], and some kinds of bile 
salt [8]. Microfilaments play an important role in canalicu- 
lar contraction for bile flow [9]. These filamentous truc- 
tures are unstable polymers; the chemical balance between 
assembly and disassembly is affected by an input of 
energy that comes from the hydrolysis of GTP or ATP 
[ 10-12]. Microtubules are especially labile structures which 
depolymerize at low temperatures [ 10] and are sensitive to 
Ca e+ [13-15] or oxyradicals [16]. These facts have led us 
to the hypothesis that, like disruption of cell membrane 
structures, disorganization of the cytoskeleton plays a 
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causal role in postischemic liver dysfunction. Most studies 
on the biology of the cytoskeleton have been performed on 
cultured hepatocytes. However, in order to understand the 
structural changes in pathological conditions such as is- 
chemia/reperfusion, it is indispensable to observe the 
cytoskeletal organization of the liver in situ. Also, to 
clarify the relationship of ischemia-induced hepatocellular 
dysfunction to cytoskeletal alterations, an in vivo assay 
system for evaluation of the cytoskeleton-associated liver 
functions is required. 
Indocyanine green (ICG) is a cholephilic anion which is 
taken up by the hepatocytes across the sinusoidal plasma 
membrane with a high extraction ratio and is removed by 
cytoplasmic transport and exclusive biliary excretion [17- 
19]. Although removal kinetics have not been fully under- 
stood, several groups have proposed the role of micro- 
tubules in cytoplasmic transport of ICG [20,21]. We have 
recently developed a spectrophotometric method for con- 
tinuous monitoring of hepatic absorbance of ICG after 
intravenous bolus injection, enabling us to evaluate indi- 
vidual clearance-processes of dye uptake by and removal 
from the liver using two exponential rate constants termed 
e~ and 13 [22]. We also have confirmed that treatment with 
colchicine, a microtubules toxin, causes a decrease in the 
second rate constant ~, i.e. an index of ICG removal. 
Therefore, changes in microtubule-mediated liver function 
during ischemia/reperfusion are reflected in the rate con- 
stant 13. 
In the present paper, using rabbits, we examined the 
effect of ischemia/reperfusion on hepatic ICG removal as 
assessed by spectrophotometric determination of dye con- 
tent within the liver. At the same time, preparing tissue 
sections of the liver, we observed by immunohistochem- 
istry whether ischemia induces disorganization of micro- 
tubules, and then the relationship between the disordered 
dye removal and alterations of the microtubular network 
was explored. We also examined whether, at a late phase 
after reperfusion or by treatment with prostaglandin E~ 
(PGE~), a possible cytoprotective agent, the alterations in 
the cytoskeleton can be prevented. 
2. Materials and methods 
2.1. Animals 
Male rabbits weighing 2.0-2.4 kg were maintained on 
laboratory chow. All animals received human care in 
compliance with the institution's guidelines. The rabbits 
were fasted overnight, but allowed to drink water freely. 
2.2. Chemicals 
The following chemicals and antibodies were purchased 
from commercial suppliers: ICG, Daiichi Pure Chemicals 
Co. (Tokyo, Japan); colchicine, Sigma Chemical Co. (St. 
Louis, MO); monoclonal mouse anti-13-tubulin, Amersham 
Corp. (Buckinghamshire, UK); fluorescein isothiocyanate 
(FITC)-labelled goat anti-mouse IgG, Jackson ImmunoRe- 
search Lab. (West Grove, PA); rhodamine-phalloidin, 
Molecular Probes (Eugene, OR); normal mouse IgG, Cap- 
pel (Cochranville, PA). Crystalline PGE~ was a gift from 
Ono Pharm. Co., Osaka, Japan. 
2.3. Operations 
Under anesthesia with intravenous injection of sodium 
pentobarbital at a dose of 50 mg/kg,  the left internal 
carotid artery was cannulated with a polyethylene tube for 
blood pressure monitoring with an electromanometer. Lac- 
tate Ringer's solution was infused during the experiments 
at a rate of 10 ml /kg per h from the left external jugular 
vein. Respiration was maintained by mechanical ventila- 
tion through an endotracheal tube installed during a tra- 
cheostomy. Pancuronium bromide was given at a dose of 
0.2 mg/kg,  and sodium pentobarbital was added as needed. 
Heparin (200 IU/kg)  was injected to interfere with micro- 
circulatory perfusion failure. After laparotomy, the liga- 
mentous attachment from the liver to the diaphragm was 
severed and the liver was exposed. Liver ischemia was 
performed by clamping the inflow vessels to three of four 
major hepatic lobes for 60 min, whereas the right-posterior 
lobe, whose inflow vessels originates first from the hepato- 
duodenal igament, was left open to avoid intestinal con- 
gestion. 
2.4. Hepatic ICG clearance 
Liver function following ischemia-reperfusion was as- 
sessed by directly measuring the hepatic clearance of ICG 
in four groups of rabbits, including a control group (n = 5), 
animals subjected to the hepatic ischemia followed by 1 h 
(n = 5) and 24 h of reperfusion (n = 5), and animals 
which received an intravenous infusion of PGE 1 at a dose 
of 0.05 txg/kg per min, from 30 min prior to the inflow 
occlusion until 1 h after reperfusion (n = 5). No obvious 
changes in arterial pressure were induced by treatment 
with this low dose of PGE~ during the operation. ICG was 
administered via the jugular catheter at a dose of 0.5 
mg/kg.  ICG content in the liver was determined spec- 
trophotometrically as we have been previously reported in 
detail [22]. Briefly, the continuous wave spectrum of the 
liver was measured for 15 min after i.v. injection of ICG at 
every 2 nm from 700 to 1000 nm, using an MCPD 1000 
photodiode scanner (Otsuka Electronics, Osaka, Japan). 
Two quartz fibers, which were connected to a light source 
and a photodiode array respectively, were brought into 
contact with the surface of the left-central lobe. A multi- 
component curve-fitting analysis was performed for the 
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Fig. 1. Schematic presentation of the two-compartment model used for 
analysis of hepatic ICG profile. The hypothetical hepatic influx curve [A] 
and the hypothetical hepatic disappearance curve [B] are expressed 
respectively as Y = - Coexp( -  at )  and Y = Coexp( -  13t). The predicted 
hepatic ICG concentration curve [C] is obtained as Y = - Coexp( -  a t )+ 
Coexp( -13t ) .  Y scales show the hepatic ICG concentration (arbitrary 
unit). C O , initial hepatic concentration. 
quantification of ICG content within the liver with the 
following Eq. (1): 
L(A) el(A) [ICG]liver = O.D.(A) - L(A) {[control iver] 
- %(A) A[oxy-hemoglobin] 
-- if3 (• )  k[deoxy-hemoglobin] 
- e4(A) A[oxidized cytochromeaa 3 ]
- es(A) A[reduced cytochromeaa 3 ]} (1) 
where L(R), el.5(h) and O.D.(h) represent he mean light 
pathlength, molar absorption coefficients of each compo- 
nent and optical density at h nm, respectively. A control 
liver spectrum was obtained before an injection of ICG. 
The mean light pathlength can be regarded as constant at 
each wavelength since the distance and angle between the 
two fibers were constant (10 mm and 50 degrees) and the 
deformed absorption spectrum due to the photon scattering 
effect of living tissue was corrected, as described else- 
where [23]. For pharmacokinetic analysis of ICG profile in 
the liver, a two-compartment model whose two exponen- 
tial coefficients can be regarded as the same as the transfer 
coefficients was employed (Fig. 1). The theoretical back- 
ground for kinetic analysis has been described before [22]. 
The hepatic ICG concentration curve was then determined 
as follows: 
[ICG]liver(t ) = -Aexp( -a t )  + Bexp( - f i t )  
(a>f l ,  A=B).  (2) 
Where [ICG]liver(t) is the hepatic concentration of ICG 
at time of t, c~ and [3 (min- 1 ) are the rate constants for the 
dye influx to the liver and disappearance from the liver, 
respectively. Constants A and B are the zero-time inter- 
cepts, both theoretically equal to the initial hepatic concen- 
tration (arbitrary unit). Dumping Gauss-Newton method, a 
nonlinear least squares curve-fitting method, was per- 
formed for the time-course plotting of the hepatic concen- 
tration of ICG. The validity of analysis can be checked 
with the value of residual sum of squares. It has been 
confirmed that the first exponential rate constant ot reflects 
the dye uptake from plasma to the hepatocytes, usually 
influenced by the microcirculatory condition in the liver, 
while the second exponential rate constant 13 represents the 
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Fig. 2. Representative time-course plotting of hepatic ICG concentrations and their fitted curves after ICG i.v. at a dose of 0.5 mg/kg.  1H, 1 h after 
reperfusion; 24H, 24 h after reperfusion; PG, intravenous infusion of PGEt (0.05 ~g/kg /min)  from 30 min prior to the inflow occlusion until 1 h after 
reperfusion. Values of cx, [3, A and B show the constants in each fitted curve represented by [ICC]liver(t) = -Aexp( -a  t) + Bexp( -  13t). ss, residual sum 
of squares. 
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Table 1 
Comparison of hepatic ICG clearance among the three ischemia-reperfusion groups and the control group 
ct (min -  t ) 15 (min -  i ) A a B a 
Control (n = 5) 1.069 4- 0.071 0.100 + 0.008 1.621 -4- 0.194 1.841 -4- 0.221 
1H (n = 5) 1.128 + 0.105 0.026 + 0.009 * 1.428 -4- 0.163 1.880 + 0.092 
24H (n = 5) 1.251 4- 0.156 0.084 4- 0.005 * 2.219 4- 0.345 2.371 4- 0.334 
1H + PG (n = 5) 0.878 + 0.057 0.089 + 0.014 t* 1.990 + 0.247 2.258 4- 0.255 
All results represent mean + S.E.M. ct, 13, A and B were determined by fitting the time-course curve of hepatic ICG concentration to the equation: 
[ICG]llver(t) = -Aexp( -c t  t) + Bexp( -  13 t). 1H, 1 h after reperfusion; 24H, 24 h after reperfusion; PG, intravenous infusion of PGE t (0.05 Ixg/kg/min) 
from 30 min prior to the inflow occlusion until 1 h after reperfusion. 
a Arbitrary unit. 
* Significantly different from control, P < 0.01. 
t Significantly different from 1H, P < 0.05. t, p < 0.01. 
by biliary excretion, mostly affected by parenchymal liver 
damage [22]. 
2.5. Fixation and immunohistochemistry 
The liver cytoskeleton was examined immunohisto- 
chemically in tissue sections obtained from six groups of 
rabbits including a control group, animals treated with 
colchicine, animals subjected to hepatic ischemia lone or 
followed by 1 h or 24 h of reperfusion, and animals 
administered PGE1 during ischemia-reperfusion. 
Colchicine, a reagent which depolymerizes microtubules 
[24], was dissolved in saline at a concentration of 5.0 
mg/ml and injected into a mesenteric vein tributary to the 
colchicine group at a dose of 2.0 mg/kg, as described 
previously [22], two hours before liver fixation. One is- 
chemia group underwent liver fixation before declamping 
of the hepatic vessels to avoid the effects of reperfusion 
injury. For fixation, the portal vein was cannulated with an 
14-gauge catheter. The liver was perfused for a few min- 
utes with 200 ml of lactate Ringer's solution at 90 cm 
H20 hydrostatic pressure to remove blood. Then the liver 
was fixed by perfusion with 500 ml of periodate-lysine- 
paraformaldehyde (PLP) fixative [25] at the same hydro- 
static pressure. All perfusion fluids were maintained at 
37°C since microtubules rapidly disassemble at low tem- 
peratures [13]. From the left-central lobe, five tissue pieces 
(5 mm in thickness) were obtained using a surgical knife. 
T 
Fig. 3. Double staining for 13-tubulin and F-actin. (upper panel) The control liver. Microtubules form extensive networks throughout the cytoplasm (a). 
Microtubule-organizing centers are shown (arrowheads). Microfilaments are seen along the cell periphery, and especially concentrated around bile 
canaliculi (b). (lower panel) The liver treated with colchicine. The microtubular network is not observed, and only diffuse cytoplasmic fluorescence exists 
(c). The distribution of microfilaments is not changed by the colchicine treatment (d). Original magnification: x 1000. 
H. Shinohara et al. / Biochimica et Biophysica Acta 1317 (1996) 27-35 31 
They were immersed in PLP fixative for 6 h and then 
placed overnight in phosphate-buffered saline (PBS) con- 
taining 4% formaldehyde. After fixation, the tissue pieces 
were successively immersed in PBS containing 10%, 15%, 
and 20% sucrose for 90 min each, and frozen in liquid 
nitrogen. Cryosections (5 Ixm thickness) were cut using a 
HISTOSTAT 975C cryostat microtome (Reichert-Jung, 
New York, USA), mounted on glass slides, and rinsed two 
times in PBS containing 10 mM glycine for 5 min, then 
immersed in PBS containing 2% gelatin and 1% goat 
serum for 30 min at 37°C, and rinsed two more times in 
PBS containing glycine for 5 min. The sections were 
processed for double staining of microtubules and micro- 
filaments. Microtubules were labeled by incubating the 
sections with monoclonal mouse anti-[3-tubulin antibody 
overnight at 4°C, and FITC-labelled goat anti-mouse IgG 
antibody for 60 min at room temperature. Microfilaments 
were made visible on the same sections by mixing rho- 
damine-phalloidin to the secondary antibody solution. As 
histochemical controls, sections from corresponding rab- 
bits were incubated with non-immune mouse IgG. All 
sections were observed by a Zeiss Axiophot fluorescence 
microscope (Zeiss, Germany). 
2.6. Statistics 
Comparison between control and experimental groups 
were made using analysis of variance (ANOVA), with 
results considered statistically different if a P value was 
less than 0.05. The values are expressed as mean _+ S.E.M. 
Fig. 4. Double staining for 13-tubulin and F-actin. (upper panel) The liver at the end of 60-rain ischemia. Microtubules appear as short fragments and the 
extensive network isnot observed (a). (middle panel) The liver 1 h after eperfusion. The fragmentation of microtubules is enhanced (c). (lower panel) The 
liver 24 h after eperfusion. Microtubules are restored to show a normal network pattern (e). Microfilaments remains largely unchanged at the end of 
ischemia (b), and both 1 h (d) or 24 h after eperfusion (f). Original magnification: X 1000. 
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3. Results 
3.1. Hepatic ICG clearance 
Fig. 2 shows representative time-course changes in 
hepatic ICG concentration and their fitted curves for each 
experimental group. Table 1 shows a comparison of the 
rate constant tx and [~, which respectively reflect ICG 
uptake by and removal from the hepatocytes, and constant 
A and B among the three ischemia-reperfusion groups and 
the control group. The values of et calculated 1h and 24 h 
after reperfusion as 1.128 ___0.105 rain -~ and 1.251 + 
0.156 min -1, respectively, were not significantly different 
from the control value of 1.069_ 0.071 min -1. By con- 
trast, 60 min-liver ischemia followed by 1 h reperfusion 
resulted in a decrease in 13 from the control value of 
0.100 + 0.008 min -j to 0.026 + 0.009 min -1. However, 
by allowing 24 h for reperfusion, 13 reversed to 0.084 __+ 
0.005 min -1. When PGE 1 was administered, 13was calcu- 
lated as 0.089 _ 0.014 min-1, indicating that the decrease 
in 13 due to 60 min-ischemia with 1 hr-reperfusion could 
be prevented by treatment with PGE~. 
3.2. Immunohistochemistry 
Fig. 3a shows microtubules in the control iver. Several 
hepatocytes showed areas of heightened fluorescence that 
appeared to be microtubule organizing centers, from which 
microtubules emanate [26]. Microtubules then form exten- 
sive networks throughout the cytoplasm. Fig. 3b depicts 
the distribution of microfilaments in the same section as 
Fig. 3a. Microfilaments were seen along the cell periphery 
showing the outline of hepatocytes in a honeycomb pat- 
tern, and especially concentrated beneath the apical mem- 
branes around bile canaliculi. Fig. 3c and d present a liver 
section obtained after pretreatment with colchicine. The 
network of microtubules was not observed, and only dif- 
fuse cytoplasmic fluorescence, possibly caused by free 
tubulin, existed (Fig. 3c). The distribution of micro- 
filaments was not changed by the colchicine treatment 
(Fig. 3d). After 60 min of liver ischemia, microtubules 
appeared as short fragments and the extensive network was 
not observed (Fig. 4a). The fragmentation f microtubules 
became more evident 1 h after reperfusion (Fig. 4c). 
However, 24 h after reperfusion, microtubules were re- 
stored to a normal network pattern (Fig. 4e). On the other 
hand, microfilaments in the hepatocytes inflicted with the 
60-min ischemia remained largely unchanged (Fig. 4b), 
and both 1 h (Fig. 4d) or 24 h of reperfusion did not 
change the distribution (Fig. 4f). When PGE 1 was given 
during the ischemia-reperfusion procedure, networks of 
microtubules were preserved even 1 h after reperfusion 
(Fig. 5a), and the peripheral distribution of microfilaments 
was also retained (Fig. 5b). 
4. Discussion 
Although the mechanism of postischemic liver cell 
injury and the resultant dysfunction have been extensively 
investigated, many researchers have focused on alterations 
of the plasma membrane [2,3]. In the present study, we 
paid attention to functional and morphological changes in 
the cytoskeleton, composed of labile cytoplasmic struc- 
tures providing the machinery for cell functions. It is well 
known that microtubules are especially labile structures 
[10], and are involved in cytoplasmic transport of various 
secretory materials [6-8]. However, understanding the sig- 
nificance of microtubules in postischemic liver dysfunction 
has been hampered, since most studies on the character- 
istics of microtubules have been performed on cultured 
hepatocytes. Therefore, we applied an immunohistochemi- 
cal technique which enabled us to clearly observe the 
microtubular network in situ. The extensive filament struc- 
tures in the control livers, the disappearance of the fila- 
ment staining after treatment with colchicine, and the 
absence of immunofluorescence in the sections without he 
first antibody (data not shown), all indicate that immunola- 
beling is specific to microtubules. Furthermore, we exam- 
ined the relationship of postischemic liver dysfunction to 
alterations of the microtubular network, using an in vivo 
assay system for evaluation of hepatic ICG clearance. 
Fig. 5. Double staining for 13-tubulin and F-actin in the PGE~-treated liver 1 h after reperfusion which followed 60-min ischemia. The network of 
microtubules i preserved (a), and the peripheral distribution of microfilaments is also retained (b). Original magnification: × 10130. 
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4.1. Ischemic changes in microtubules 
We observed isruption and rebuilding of microtubular 
networks following 60 rain of liver ischemia. At least two 
biochemical factors, namely cellular GTP levels and cy- 
tosolic Ca 2+ concentrations, should be considered in clari- 
fying the mechanism. 
Microtubular formation by continuous assembly and 
disassembly of tubulin heterodimers consisting of c~- and 
[3-tubulin has been explained as dynamic instability [10], 
which is controlled by the nucleotide GTP; polymerization 
requires bindings of GTP to [3-tubulin, and depolymeriza- 
tion is induced by hydrolysis of GTP to weaken the bonds 
between tubulin subunits in the microtubules [11]. When 
blood flow to the liver is interrupted, the decrease in tissue 
oxygen stops the mitochondrial electron flow, resulting in 
depletion of ATP [27,28]. Since ATP serves GDP with 
high-energy phosphates to form GTP, the decrease in ATP 
can prevent free tubulin molecules from polymerization. 
Thus, suppressed cellular energy status may be responsible 
for the disorganization of microtubular networks following 
liver ischemia. However, judging from our immunohisto- 
chemical findings, depolymerization of microtubules ap- 
pears to occur during reperfusion rather than in right after 
ischemia. Since ATP levels in hepatocytes markedly de- 
crease during ischemia with some recovery during reperfu- 
sion, these results indicate that only cellular energy status 
itself cannot illustrate the insult. 
Microtubules disassemble in the presence of a millimo- 
lar concentration of Ca z+ in vitro [13], presumably by the 
intrinsic inhibitory effect of Ca 2+ on nucleation of the 
tubulin heterodimer [29], and alternatively, by the indirect 
effect of phosphorylation of microtubule associated pro- 
teins (MAPs) with a Ca2+/calmodulin-dependent kinase; 
that is, phosphorylation of MAPs in turn leads to an 
inhibition of the MAPs-facilitated microtubule assembly 
and stability [15,30,31]. Cytosolic Ca 2+ concentration is
maintained at a very low level (10 -7 M); in hepatocytes 
this occurs mainly by the operation of an ATP-dependent 
plasma membrane Ca 2+ translocase which continuously 
extrudes Ca 2+ against its concentration gradient [32]. It 
has been suggested that the accumulation of Ca 2+ in the 
cytosol plays a crucial role in reperfusion cell injury [33]. 
Insufficient recovery of ATP synthesis could not sustain 
active effiux of Ca 2+ from the postischemic hepatocytes. 
Alternatively, oxyradicals formed by oxidative stress fol- 
lowing reperfusion may be a cause of Ca 2+ overload in 
hepatocytes [3]. Consequently, if Ca 2+ is also relevant as 
an inhibitor of tubulin polymerization i  vivo, Ca 2+ in- 
crease would be associated with the extensive microtubular 
disorganization after reperfusion. Furthermore, it may be 
possible that oxyradicals directly affect the instability of 
microtubules, since the presence of pro-oxidants inhibit 
tubulin polymerization i vitro [16]. 
The question arises as to whether the disorganization of
microtubules following liver ischemia is a reversible 
change, and if so, how long after reperfusion reconstruc- 
tion of the network takes. Results showing the well-con- 
stituted structures of microtubules observed 24 h after 
reperfusion demonstrated that the disruption of organelles 
caused by 60 min-liver ischemia is reversible damage. The 
critical duration of liver ischemia leading to irreversible 
changes in microtubules was not studied in the present 
study. A previous report dealing with canine hearts demon- 
strated that 40 min of coronary occlusion leads to a loss of 
microtubule staining in the myocardium after 24 h of 
reperfusion [34]. However, our observation regarding the 
liver revealed that 60 min-ischemia is a permissible dura- 
tion for reversible changes. The discrepancy between criti- 
cal durations of irreversible damage of microtubules may 
stem from differences in MAP composition between the 
heart and the liver [31]. 
4.2. Changes in cytoplasmic ICG transport 
NIR spectroscopy enables us to directly evaluate indi- 
vidual ICG clearance-processes of uptake by and removal 
from the liver [22]. The rate constant ~ represents the 
former process but is largely influenced by hepatic blood 
perfusion since ICG is taken up by carrier-mediated trans- 
port with a high extraction ratio [17-19]. The current 
knowledge using intravital microscopy is that deterioration 
in liver microcirculation would be a significant cause of 
reperfusion failure to determine postischemic liver dys- 
function [35]. In the present study, however, 1 h- as well as 
24 h-reperfusion did not bring any significant decrease in 
~. This incompatibility may be explained by the transient 
enhancement of the blood flow in the ischemically injured 
lobe, where we have previously found an increase in tissue 
oxgenation rather than in a liver at physiological condi- 
tions [22]. 
Microtubules in liver cells serve as lines of cytoplasmic 
transport of organelles and various secretory materials via 
vesicles [9], and therefore the biliary excretion of the 
materials is inhibited by treatment with colchicine or other 
microtubule toxins, probably as a consequence of micro- 
tubular disruption. Although it is not known exactly 
whether ICG is transported via vesicles or not, several 
studies show that excretion of the dye into bile is reduced 
by treatment with colchicine [20,21] providing us evidence 
that microtubules play an important role in the cytoplasmic 
transport of ICG. The rate constant [3 in this NIR spectro- 
scopic method contains infomaation about ICG removal 
including cytoplasmic transport and biliary excretion which 
mostly depends on cellular ATP levels, since treatment 
with either colchicine or with ouabain, an inhibitor of 
Na+,K+-ATPase, caused a decrease in [3 [22]. Immunohis- 
tochemistry performed here showing the disruption of 
microtubular networks by treatment with colchicine (Fig. 
3c) revealed that the structural changes in microtubules 
can be reflected in the rate constant [3. In the present study, 
ischemia caused a decrease in [3 in the early phase of 
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reperfusion, whereas in the late phase after reperfusion 13's 
decrease appeared to be reversed. Also, this time-course in
the decrease and subsequent recovery of 13 closely corre- 
lated with the disruption and rebuilding of microtubular 
structures observed with immunohistochemistry. There- 
fore, we assume that disorganization of microtubular net- 
works occurring with liver ischemia is, at least in part, 
responsible for the dysfunction i  cytoplasmic transport of 
ICG. 
4.3. Beneficial effect of PGE 1 on microtubular organiza- 
tion 
Disorganization of microtubules and disturbance of ICG 
removal were both prevented by treatment with PGE~. 
Recently, a cytoprotective action of PGE~ on postischemic 
livers has been widely accepted. Stabilization of membrane 
microviscosity [36,37], preservation of mitochondrial phos- 
phorylative function to ameliorate ATP resynthesis [38], 
acceleration of Ca 2÷ efflux [39], and inhibition of oxyradi- 
cal production [40], all seem to be possible mechanisms for 
the beneficial effect of PGE 1. A previous study in rats 
demonstrated that PGE 2 enhances biliary excretion of 
ICG, but does not affect ICG extraction and bile flow, 
suggesting that PGE 2 can induce an increase in cytoplas- 
mic transport of ICG [41]. This hypothesis seems compati- 
ble with our spectrophotometric results that postischemic 
damage of ICG removal was prevented by treatment with 
PGE z, since the structure and biological activities of PGE~ 
are known to be almost identical to those of PGE 2 [42]. 
Thus, it appears that inhibition of Ca2+-overload and/or 
amelioration of ATP resynthesis nduced by treatment with 
PGE~ may be responsible for the early reorganization of
the microtubular network, and the subsequent rapid recov- 
ery of ICG transport in the postischemic hepatocytes. 
In conclusion, we observed the disruption of micro- 
tubules following 60 min of liver ischemia. This cyto- 
skeletal alteration was evident at 1 h but was not observed 
at 24 h after reperfusion, and treatment with PGEI exerted 
its beneficial effect by preserving the microtubular net- 
work. The derangement and subsequent rebuilding of mi- 
crotubular structures correlated well with changes in hep- 
atic ICG removal. Considering the physiological functions 
of microtubules, the disorganization of microtubular net- 
work may be a cause of postischemic liver dysfunction. 
These results attract attention to the significance of cyto- 
skeletal changes in liver cell injury from ischemia and 
subsequent reperfusion. 
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